Clinical Trial Update: Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

View source ↗

Summary

This clinical trial update reports on an observational study evaluating how nurse support and disease factors influence long-term adherence to Betaferon (interf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Betaferon (interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Relapsing Remitting Multiple Sclerosis (RRMS) | Status: COMPLETED